Schedule 13D ownership disclosure
NAVIDEA BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 63937X202
Event date: 2022-04-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 31.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-048866
- Form type
- SC 13D
- Filer
- NAVIDEA BIOPHARMACEUTICALS, INC.
- CIK
- CIK 810509
- Filed
- Apr 22, 2022
- Reporting period
- Apr 10, 2022
- Description
- Schedule 13D beneficial ownership